Good morning :)
Place Order
Add to Watchlist

Thyrocare Technologies Ltd

THYROCARE

Thyrocare Technologies Ltd

THYROCARE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹4,095 cr, stock is ranked 814
Moderate RiskStock is 2.63x as volatile as Nifty
777.850.56% (+4.35)
777.850.56% (+4.35)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹4,095 cr, stock is ranked 814
Moderate RiskStock is 2.63x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹4,095 cr, stock is ranked 814
Moderate RiskStock is 2.63x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
52.757.652.33%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
46.016.090.55%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 2 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Thyrocare Technologies Limited is a diagnostic chain company which offers a range of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.

Investor Presentation

View older 

Aug 1, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.06%, vs industry avg of 10.07%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 1.12% to 0.95%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -3.63%, vs industry avg of 42.88%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue247.51316.63379.32413.52441.44507.05618.11536.27581.64606.39
Raw Materialssubtract69.6881.7894.61110.79117.17163.86170.57163.03434.45448.91
Power & Fuel Costsubtract5.326.356.687.778.697.648.4010.71
Employee Costsubtract25.7032.0035.3443.3548.9258.0761.13106.15
Selling & Administrative Expensessubtract28.8946.1449.5759.2744.4842.1645.4751.69
Operating & Other expensessubtract17.3350.1727.5927.5048.0151.7067.7472.56
Depreciation/Amortizationsubtract18.2418.0520.1026.1731.9130.2833.8738.7147.0148.54
Interest & Other Itemssubtract0.550.460.440.611.850.873.214.834.204.31
Taxes & Other Itemssubtract30.0038.8351.7152.9252.0139.3251.5824.2325.2226.99
EPS9.947.9817.3615.9916.7421.4133.3012.1613.4214.67
DPS10.0010.0010.0020.005.0025.0015.0018.0018.000.00
Payout ratio1.011.250.581.250.301.170.451.481.340.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

May 10PDF
FY 2022

Annual report

PDF

Investor Presentation

Apr 30PDF
Feb 12PDF
Feb 12PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

Feb 3PDF
Nov 11PDF
Aug 1PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 1PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Thyrocare Technologies Ltd57.887.652.33%
Apollo Hospitals Enterprise Ltd102.1814.060.09%
Max Healthcare Institute Ltd85.1412.150.16%
Fortis Healthcare Ltd63.464.440.20%

Price Comparison

Compare THYROCARE with any stock or ETF
Compare THYROCARE with any stock or ETF
THYROCARE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.11%12.84%2.05%2.49%11.50%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun10.00%3.44%3.46%3.35%2.90%2.49%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Thyrocare Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Nippon India Small Cap Fund - Growth - Direct Plan

Growth
2.7668%0.20%-0.03%157/230 (-3)
Nippon India Pharma Fund - Growth - Direct Plan

Growth
2.7476%1.52%0.06%24/37 (0)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth

Growth
1.1904%1.18%-0.01%30/51 (-4)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Trend In Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

THYROCARE has shown inconsistent dividend trend over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 2.33%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹23.26 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateApr 20, 2023

Interim
Interim | Div/Share: ₹18.00

Dividend/Share

18.00

Ex DateEx Date

Apr 20, 2023

Cash Dividend

Ex DateEx DateMay 11, 2022

Interim
Interim | Div/Share: ₹15.00

Dividend/Share

15.00

Ex DateEx Date

May 11, 2022

Cash Dividend

Ex DateEx DateJun 17, 2021

Final
Final | Div/Share: ₹15.00

Dividend/Share

15.00

Ex DateEx Date

Jun 17, 2021

Cash Dividend

Ex DateEx DateNov 12, 2020

Interim
Interim | Div/Share: ₹10.00

Dividend/Share

10.00

Ex DateEx Date

Nov 12, 2020

Cash Dividend

Ex DateEx DateNov 21, 2019

Interim
Interim | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Nov 21, 2019

News & Opinions

Thyrocare expands Northern India presence with Polo Labs acquisition

19 hours agoBusiness Standard

Thyrocare Q1 Results Review - Margin Thesis Is Starting To Unfold: ICICI Securities

2 days agoBloomberg Quint

Gainers & Losers: Dabur, Avanti Feeds among 9 stocks in limelight on Wednesday

2 days agoEconomic Times

Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-Street

2 days agoEconomic Times

Thyrocare Tech stock skyrockets 17% post Q1FY25 results; details here

2 days agoBusiness Standard
Live Market Update
Broader mkt outperforms; financial services shares under pressure

The key equity indices traded with limited losses in the mid-afternoon trade. The Nifty traded below the 24,400 level after hitting the day's high of 24,504.25 in early trade. Financial services shares extended loss for the two consecutive trading sessions. At 14:30 IST, the barometer index, the S&P BSE Sensex, was down 358.86 points or 0.44% to 80,088.97. The Nifty 50 index declined 91 points or 0.37% 24,392.75. The broader market outperformed the headline indices. The S&P BSE Mid-Cap index rose 0.60% and the S&P BSE Small-Cap index added 1.60%. The market breadth was strong. On the BSE, 2,703 shares rose and 1,136 shares fell. A total of 120 shares were unchanged. Economy: Seasonally adjusted index, HSBC Flash India Composite Output Index rose from 60.9 in June to 61.4 at the start of the second fiscal quarter. Growth strengthened at goods producers and service providers, with the former leading the upturn, the strongest rate of expansion for three months. HSBC Flash India Manufacturing PMI stood at 58.5 in July as against 58.3 in June, signalling a historically strong improvement in the health of the sector. Anecdotal evidence suggested that favourable market conditions and new business gains underpinned the upturn in private sector activity. HSBC Flash India Services PMI Business Activity Index stood at 61.1 in July as compared with 60.5 in June while HSBC Flash India Manufacturing PMI Output Index increased to 62.2 in July from 61.9 in June. The latest results also revealed that rising material and labour costs added to inflationary pressures. In particular, selling prices rose to the greatest extent since February 2013. Pranjul Bhandari, Chief India Economist at HSBC, said: 'The Flash Composite Output Index signalled continued robust growth in India's private sector. The rise in output in July was led by a further increase in business activity in the manufacturing sector, while the pace of expansion in services output also accelerated and remained well above its long-run average. As a result, companies turned more optimistic in July, following a moderation in business confidence in June. We note that the rate of input cost inflation continued to trend higher in both sectors, which has driven firms to keep raising sales prices.' Buzzing Index: The Nifty Financial Services index fell 1.16% to 23,034.75. The index declined 2.50% in the two trading sessions. Bajaj Finserv (down 3.03%), Axis Bank (down 2.58%), Bajaj Finance (down 2.07%), Shriram Finance (down 1.72%) and State Bank of India (down 1.55%), Kotak Mahindra Bank (down 1.53%), HDFC Bank (down 1.29%), ICICI Bank (down 1.14%), Cholamandalam Investment & Finance Company (down 0.82%) and IDFC (down 0.77%) slipped. On the other hand, ICICI Prudential Life Insurance Company (up 7.57%) ,HDFC Life Insurance Company (up 3.61%) and LIC Housing Finance (up 2.41%) advanced. Numbers to Track: The yield on India's 10-year benchmark federal rallied 1.65% to 7.085 as compared with previous close 6.970. In the foreign exchange market, the rupee lower against the dollar. The partially convertible rupee was hovering at 83.7125, compared with its close of 83.6950 during the previous trading session. MCX Gold futures for 5 August 2024 settlement rose 0.42% to Rs 68,794. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.06% to 104.51. The United States 10-year bond yield shed 0.02% to 4.238. In the commodities market, Brent crude for September 2024 settlement added 59 cents or 0.73% to $81.60 a barrel. Stocks in Spotlight: Thyrocare Technologies zoomed 16% after the healthcare service provider reported 39.71% increase in consolidated net profit to Rs 24.17 crore in Q1 FY25 from Rs 17.30 crore posted in Q1 FY24. Revenue from operations grew by 16.32% year on year (YoY) to Rs 156.91 crore in the quarter ended 30 June 2024. Schaeffler India rallied 5.87% after the company reported 6.82% increase in standalone net profit to Rs 253.54 crore in Q2 CY24 as against Rs 237.2 crore posted in Q2 CY23. Revenue from operations jumped 13.27% year on year (YoY) to Rs 2,071.9 crore in Q2 CY24. Bajaj Finserv declined 2.53%. The company's consolidated net profit jumped 10.04% to Rs 2,137.70 crore on a 35.22% increase in total income to Rs 31,480.14 crore in Q1 FY25 over Q1 FY24.Powered by Capital Market - Live

2 days agoCapital Market - Live

Thyrocare Tech hits 52 week high as Q1 PAT climbs 40% YoY

2 days agoBusiness Standard

Thyrocare Technologies consolidated net profit rises 39.71% in the June 2024 quarter

3 days agoBusiness Standard
Earnings
Thyrocare Technologies consolidated net profit rises 39.71% in the June 2024 quarter

Net profit of Thyrocare Technologies rose 39.71% to Rs 24.17 crore in the quarter ended June 2024 as against Rs 17.30 crore during the previous quarter ended June 2023. Sales rose 16.32% to Rs 156.91 crore in the quarter ended June 2024 as against Rs 134.89 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales156.91134.89 16 OPM %26.9525.58 - PBDT44.9134.73 29 PBT33.5524.90 35 NP24.1717.30 40 Powered by Capital Market - Live

3 days agoCapital Market - Live

Q1 results today: HUL, Bajaj Finance among 34 companies to announce earnings on Tuesday

3 days agoEconomic Times